Literature DB >> 24506660

A case of Degos disease: demonstration of C5b-9-mediated vascular injury.

Masayu Umemura1, Yusuke Miwa, Ryo Yanai, Sakiko Isojima, Takahiro Tokunaga, Hiroyuki Tsukamoto, Ryo Takahashi, Nobuyuki Yajima, Tsuyoshi Kasama, Nanako Takahashi, Hirohiko Sueki, Sayaka Yamaguchi, Katsuhito Arai, Yoshiaki Takeuchi, Nobuyuki Ohike, Tomoko Norose, Toshiko Yamochi-Onizuka, Masafumi Takimoto.   

Abstract

A 68-year-old Japanese male presented with atrophic erythematous white lesions with peripheral dark reddish rims on his back. Multiple ulcers were detected from his stomach to his large intestine using endoscopy. Although the patient was given high doses of a steroid, aspirin, dipyridamole, and intravenous immunoglobulin therapy, he died of gastrointestinal hemorrhage, perforation and septic shock. An autopsy examination revealed pauci-inflammatory thrombotic microangiopathy with endothelial cell injury, fibrous occlusive arteriopathy, and vascular C5b-9 deposition in the wall of the gastrointestinal tract from the esophagus to the large intestine as well as in the dermis of the skin.

Entities:  

Keywords:  C5b-9 deposition; Degos disease

Mesh:

Substances:

Year:  2014        PMID: 24506660     DOI: 10.3109/14397595.2013.874761

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  4 in total

1.  Bowel perforation from malignant atrophic papulosis treated with eculizumab.

Authors:  Ajithraj Sathiyaraj; Priyanga Jayakumar; Matthew R McGlennon; John F Eckford; Sandy Itwaru Anne
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-09-14

2.  Interferon-complement loop in transplant-associated thrombotic microangiopathy.

Authors:  Sonata Jodele; Mario Medvedovic; Nathan Luebbering; Jenny Chen; Christopher E Dandoy; Benjamin L Laskin; Stella M Davies
Journal:  Blood Adv       Date:  2020-03-24

Review 3.  Gastrointestinal Kohlmeier-Degos disease: a narrative review.

Authors:  Samantha S Sattler; Cynthia M Magro; Lee Shapiro; Jamie F Merves; Rebecca Levy; Jesse Veenstra; Puraj Patel
Journal:  Orphanet J Rare Dis       Date:  2022-04-20       Impact factor: 4.303

Review 4.  Tackling COVID-19 infection through complement-targeted immunotherapy.

Authors:  Sonata Jodele; Jörg Köhl
Journal:  Br J Pharmacol       Date:  2020-07-27       Impact factor: 9.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.